drugset / Trial / NCT02137538

Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole

NCT02137538

Phase 4 Completed 79 enrolled Stanford University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to determine if there are differences in the final height or hormone profile of short pubertal boys placed on different forms of aromatase inhibitor now routinely used to increase stature: Anastrozole and Letrozole. It also should determine if there are differences in the side effect profiles of the two drugs to be used.

Timeline

Start
2009-11-18
Primary completion
2018-06-05
Completion
2018-06-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Anastrozole Other / unclassified 1 mg Oral
Comparator Letrozole Other / unclassified 2.5 mg Oral